You do understand that information was taken from the company generated press releases. As usual all sizzle no steak or as they say in Texas - all hat, no cattle.
From the article:
"The company has completed Phase 1 clinical trials for RPI-78M, but these results have not been published."
"In September 2016, Nutra Pharma announced a partnership with Omnia Biologics to prepare for the upcoming clinical trials. Omnia Biologics will clone and purify the alpha-cobratoxin gene required to produce RPI-78M. Nutra Pharma has announced a similar collaboration on May 31, 2017, with the University of Maryland’s Bioprocess Scale-up Facility (BSF), which will aim to optimize the sustainable production of RPI-78M at high quality, using the cloned gene."
Well none of that is true and oddly Deitsch hasn't published the results from the clinical trials.
Why isn't the research and clinical trials listed on ClinicalTrials.gov? Deitsch hasn't started any FDA approved clinical trials.
IG
News 
Market Data 
Discover 
